Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Antiretroviral therapy for prevention of HIV transmission: implications for EuropeV Cambiano, J O'Connor, A N Phillips, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
AIDS (London, England)|September 14, 2000
Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. Royal Free Centre for HIV MedicineM Youle, G Janossy, W Turnbull, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Lancet (London, England)|April 28, 1999
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study GroupG J Weverling, A Mocroft, B Ledergerber, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Antiretroviral therapy for prevention of HIV transmission: implications for EuropeV Cambiano, J O'Connor, A N Phillips, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
AIDS (London, England)|September 14, 2000
Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. Royal Free Centre for HIV MedicineM Youle, G Janossy, W Turnbull, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Lancet (London, England)|April 28, 1999
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study GroupG J Weverling, A Mocroft, B Ledergerber, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Pageof 24